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Objective: Low vision that causes forfeiture of driver’s licenses and collection of disability 
pension benefits can lead to negative psychosocial and economic consequences. The purpose of 
this study was to review the requirements for holding a driver’s license and rules for obtaining 
a disability pension due to low vision. Results highlight the possibility of using a milestone 
approach to describe progressive eye disease.
Methods: Government and research reports, websites, and journal articles were evaluated to 
review rules and requirements in Germany, Spain, Italy, France, the UK, and the US.
Results: Visual acuity limits are present in all driver’s license regulations. In most countries, 
the visual acuity limit is 0.5. Visual field limits are included in some driver’s license regulations. 
In Europe, binocular visual field requirements typically follow the European Union standard 
of $120°. In the US, the visual field requirements are typically between 110° and 140°. Some 
countries distinguish between being partially sighted and blind in the definition of legal blind-
ness, and in others there is only one limit.
Conclusions: Loss of driving privileges could be used as a milestone to monitor progres-
sive eye disease. Forfeiture could be standardized as a best-corrected visual acuity of ,0.5 or 
visual field of ,120°, which is consistent in most countries. However, requirements to receive 
disability pensions were too variable to standardize as milestones in progressive eye disease. 
Implementation of the World Health Organization criteria for low vision and blindness would 
help to establish better comparability between countries.
Keywords: driver’s license requirements, glaucoma, health outcomes, progressive eye 
disease
Introduction
Maintaining mobility outside the home is an essential part of independent and active 
living for the elderly. Driving is often the most convenient form of transportation, 
especially in places with limited or no public transportation services. It is the primary 
means of transportation among the elderly in the US1,2 and is becoming increasingly 
important in Europe.3,4 Visual cues provide the most crucial sensory information for 
safe driving performance.5,6 Although many factors contribute to safe driving, crash 
rates and driving-related injuries have been associated with deteriorating vision.5,7,8 
Consequently, licensing authorities have instituted minimum vision requirements for 
maintaining driving privileges.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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The number of patients with visual impairments due to 
progressive eye diseases, such as glaucoma, is expected to 
rise in coming years as the population ages worldwide.8–10 
Because glaucomatous damage progresses to visual impair-
ment, many will fail to meet the vision requirements for 
legal fitness to drive and will be forced to relinquish their 
driver’s license. Unfortunately, driving cessation can lead 
to profound negative psychosocial and economic conse-
quences. For example, former drivers lose their mobility and 
independence, making it difficult to obtain essential services 
and daily goods, eg, doctors’ appointments and groceries.11 
They also reduce the frequency of contact with relatives 
and friends as social opportunities become restricted.12 
Depressive symptoms are higher in former drivers, pos-
sibly as a result of these consequences.13–15 The economic 
consequences of losing driving privileges are not merely 
limited to the former driver. Drivers who lose their license 
must also rely on others for transportation, which may be 
costly in terms of a caregiver’s time, and monetarily costly if 
the caregiver needs to make alternative work arrangements. 
As eye diseases progress to low vision and blindness, the 
former driver may no longer be able to participate fully in 
life and/or work activities, and disability pensions may be 
sought. Furthermore, people who lose the ability to drive are 
also more likely to require long-term care facilities,16 posing 
a personal and/or societal financial burden.
Fortunately, effective treatment can slow the rate of 
disease progression17,18 and potentially increase the length 
of time that a person is deemed fit to drive. For glaucoma, 
judgments about treatment effectiveness are typically based 
on intraocular pressure reduction. In recent years, research-
ers and clinicians have become increasingly concerned with 
slowing the progression of visual field loss,19 which may 
be as important as achieving target intraocular pressures. 
As a complement to visual field measurements, treatment 
effectiveness may also be considered in terms of postponing 
milestones, such as driver’s license forfeiture and receipt 
of disability benefits. Measuring the rate of progression to 
defined milestones such as these would provide an important 
link between visual field measurements and patients’ quality 
of life. However, the degree of consensus between countries 
regarding driver’s license vision requirements and entitle-
ment to disability pensions has not been clearly defined.
The purpose of the present study was to review the require-
ments for holding a driver’s license and rules for obtaining 
a disability pension due to low vision. Results underscore 
the possibility of using these outcomes as milestones to 
describe progressive eye disease by relating disease severity 
to disability. This review was conducted for five European 
Union countries and selected states within the US.
Methods
Research was conducted to identify driver’s license rules 
and requirements for passenger cars and disability pensions 
due to low vision for six countries (Germany, Spain, Italy, 
France, the UK, and the US). For each of the six countries, 
the driver’s license regulations were investigated with regard 
to visual standards. In the US, where the regulations are state-
dependent, we focused on regulations from three arbitrarily 
chosen states (California, Iowa, and New York). In Europe, 
regulations in each country have been affected by minimum 
European Union standards. The European Union Member 
States have their individual driver’s license requirements 
and guidelines, but the European Union regulations can 
potentially overrule these. Therefore, these European Union 
standards were also reported. Sources included government 
reports, research reports, government and nonprofit websites, 
and journal articles. Linguistic experts assisted with the 
review to include relevant nonEnglish documents. National 
findings and intercountry differences were reviewed, 
discussed, and verified with ophthalmology specialists from 
each country.
Results
Driver’s license requirements
Visual acuity
The most important aspects of the driver’s license require-
ments for passenger cars are summarized in Table 1 for the 
relevant European Union countries. The medical require-
ments for driver’s licensing in European countries are affected 
by the minimum standard established by the European 
Union. Drivers of cars and motorcycles are required to have 
a binocular visual acuity of at least 0.5 (20/40 feet, 6/12 
or 5/10 meters) with or without correction, and binocular 
visual field standards are limited to no less than 120°.20 
For monocular vision, applicants must have a corrected or 
uncorrected visual acuity of at least 0.6 (approximately 20/30 
feet, 6/9 meters). Also, medical authorities must certify that 
the condition has existed sufficiently long enough to allow 
adaptation and that the field of vision in the subject eye is nor-
mal. In cases where a progressive eye disease is detected or 
declared, driver’s licenses may be issued or renewed provided 
that the applicant undergoes regular medical examinations.20 
Exceptions can be made in cases duly justified by a favor-
able medical opinion and a positive practical test. At these Clinical Ophthalmology 2010:4
Table 1 Driver’s license requirements in europe
Country Visual acuity Visual field Monocular vision Other characteristics
eU 0.5 both eyes and with 
corrective lenses
no less than 120° VA $0.6 if monocular 
vision
exceptions can be made by 
medical opinion
UK number plate test (≈6/10 
to 6/15)*
At least 120° horizontally 
(no significant loss within 
central 20°)
Monocular vision if 
normal visual field
License must be revoked if 
standards not met (exceptions 
possible under eU standards)
germany Corrected VA not below 
0.5 in the best eye, 0.2 in 
the worse eye
At least 120° horizontally 
(perfect within 30°)
if monocular or worse 
eye below 0.2: best 
eye at least 0.6 VA
France Binocular acuity not 
lower than 0.5
horizontal: 60° right and 
left; vertical: 30° above 
and below
if monocular or worse 
eye below 0.1: best 
eye at least 0.6 VA
night vision necessary; can be 
exceptions for restricted 
daytime licenses
spain Best-corrected VA of at 
least 0.5
Visual field has to be 
normal
Monocular vision not 
allowed; exceptions if 
at least 0.6 VA
restrictions can be determined 
by medical experts
italy Best-corrected binocular 
VA at least 1
Normal field of vision 
(such as 120°)
Worse-seeing eye at 
least 0.2
Sufficient chromatic sense and 
nocturnal vision
Note: *0.4 to 0.6 in decimal fraction.
Abbreviations: VA, visual acuity; eU, european Union.
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examinations, attention is paid to the state of visual function, 
recovery from glare, contrast sensitivity, and twilight vision.21 
Driver’s licenses are not issued if the medical examination 
shows any other eye condition that would compromise driv-
ing safety.20
European countries generally follow the European Union 
driver’s license requirements with a few exceptions. In the 
UK, visual acuity requirements are based on the number 
plate eye test in which the applicant must be able to read a 
registration mark fixed to a motor vehicle.22–24 The number 
plate test has been thought to convert to a Snellen acuity 
of between 6/15 and 6/10 (20/50–20/40 feet or 0.4–0.6 
decimal).25,26 Monocular vision is allowed in the UK if there is 
a normal monocular visual field and no area of defect caused 
by pathology.22,27 Binocular visual acuity requirements for the 
remaining European Union countries are similar. France and 
Spain follow the European Union standard, in that both have 
a minimum binocular vision requirement of 0.5 (20/40 feet, 
5/10 meters).28,29 However, in Italy, the best-corrected visual 
acuity must be at least 1.0 (10/10, 20/20 feet, 6/6 meters) 
for binocular vision, with a minimum of 0.2 (2/10, 20/100 
feet, 6/30 meters) for the worse-seeing eye.30 In Germany, 
applicants must also have a central visual acuity of at least 
1.0 (0.7/0.7, 20/20 feet, 6/6 meters) with or without correc-
tive means.31 Stricter standards are enforced for monocular 
vision in Germany and France, which require visual acuity of 
the better eye to be at least 0.6.31 In Spain and Italy, driving 
with monocular vision is normally not allowed.
The visual acuity requirements for holding a driver’s 
license in the European Union are similar to those in the 
US states (Table 2). In California, visual acuity of 20/40 
(6/12 meters, 0.5 decimal) with or without correction is 
required.32,33 Visual acuity measurements are obtained for 
both eyes together and for each eye separately while both 
eyes remain open, as in normal driving.32,33 In New York 
and Iowa, a driver must also have 20/40 (6/12 meters, 
0.5 decimal) vision in at least one eye with or without cor-
rective lenses.34,35
Visual field
The minimum visual field requirement in the UK is at least 
120° horizontally (Table 1). Furthermore, there cannot be 
significant defects in the binocular field that encroach within 
20° of fixation above or below the horizontal meridian.24,27 
The same requirement is observed in Germany and France, 
but the central visual field up to 30° must be normal.28,31 For 
Spain and Italy, no diameter is given for visual field require-
ments. However, the field of vision, whether binocular or 
monocular, also has to be normal (eg, 120°).29,30 In the US, 
California does not have visual field requirements (Table 2). 
The standards are slightly more stringent for New York and 
Iowa compared with European Union countries. In New York, 
for individuals with corrected vision of less than 20/40 but no 
less than 20/70, the horizontal binocular field of vision must 
be no less than 140°.36 In Iowa, the visual field requirement 
is also 140° or better.34
exemptions and restrictions
To drive in the UK, the applicant has to meet the visual 
standards. If the driver is unable to meet the standards, he or Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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Table 2 Driver’s license requirements in the Us
State Visual acuity Visual field Monocular vision Other characteristics
All states Most states: 20/40  
(one or both eyes)*
some states: none; most 
states: 110° to 140°
20/40 to 20/100*** (20/40 in 
most states)
Most states allow for restrictive 
licenses
California 20/40 with or without 
corrective lenses
No visual field requirements Tested for both eyes together 
and for each eye separately
A vision specialist can determine 
ability to drive
new York 20/40 vision in at least 
one eye with or without 
corrective lenses
if VA between 20/40 and 
20/70**: 140° field of vision
A vision specialist can determine 
restrictions
iowa At least 20/40 vision in at 
least one eye, with or 
without corrective lenses
140° or better 20/40–20/50****: no headlights 
driving; 20/50 but at least 20/70: 
no driving over 35 mph
Notes: Decimal fraction equivalent: *20/40 = 0.5; **20/70 = 0.3; ***20/100 = 0.2; ****20/50 = 0.4.
Abbreviation: VA, visual acuity.
she must not drive and the license must be refused or revoked. 
However, the European Union regulations can override the 
UK standards, and the driver can apply to be considered as 
an exceptional case and granted an exemption.37 In the UK, 
licenses are normally issued to be valid until the driver is aged 
70 years, unless restricted to a shorter duration for medical 
reasons. There is no upper limit, but after the age of 70 years, 
renewal is necessary every three years.27,38
In Germany, if the applicant does not pass the test, an eye 
medical investigation is required, and minimum requirements 
of this test must be fulfilled. Central visual acuity defects 
must be corrected as much as possible. Visual acuity must 
not fall below 0.5 in the best eye and 0.2 in the worse eye.31 
Renewal is not determined by age, and there are no medical 
requirements for renewal.38
For requirements in France, in case of severe vision loss 
of an eye, the driver will temporarily lose permission to 
drive. Also, night vision is required. Restricted licenses for 
daytime driving are given only if a specialist deems that the 
visual field is normal.28 There are no age-related renewal 
procedures or medical requirements for renewal.38 In the 
case of alterations of mesopic vision or glare, restrictions 
and limitations in Spain must be determined according to 
ophthalmologic criteria so that secure driving can be guaran-
teed. Driving with diplopia is not allowed. However, exemp-
tions can be given in exceptional cases. People in Spain with 
monocular vision and a visual acuity of higher than 0.6 on 
the better-seeing eye can get permission to drive, provided 
they fulfill all other requirements and travel no faster than 
100 km/hour.39 In Spain the renewal cycles are 10 years for 
drivers younger than 45 years of age. For drivers between 
45 and 70 years of age, the renewal cycles are five years. 
For drivers who are 70 years of age or older, renewal has to 
take place every other year.40 In Italy, a medical/legal spe-
cialist and a general ophthalmologist examine the medical 
certifications, ie, ophthalmic check reports and visual field 
examinations. Candidates must possess sufficient chromatic 
sense, adequate nocturnal vision, and binocular vision.41 The 
renewal cycle in Italy is 10 years until the age of 50 years. 
Between the ages of 50 and 70 years, the renewal cycle is 
five years, whereas after age 70 years the renewal cycle is 
accelerated to an interval of three years.42
Driving requirements in the US are varied. In California, 
candidates who do not pass the vision examination may be 
referred to a vision specialist, who determines the ability to 
drive safely and may prescribe eye glasses or a stronger pre-
scription (Table 2).32,33 Renewal takes place every five years 
regardless of the age of the driver. However, drivers who are 
70 years of age or older will have to undergo a vision exami-
nation to get a renewal.43 If the driver fails the vision test, a 
supplementary driving performance evaluation (driving test) 
can be given to determine whether the driver can compensate 
for the vision impairment. If this supplementary driving test 
is passed, the driver’s license can be renewed with restrictions 
added to the license. Restrictions can include requirements 
for special mechanical devices to be placed on the vehicle, 
limiting when and where a person may drive (eg, no freeway 
driving, no nighttime driving), or requiring eye glasses or 
corrective contact lenses. In New York, if the vision test is 
not passed, further assessment must be made by a physician, 
ophthalmologist, or optometrist.36 Renewal takes place every 
five years no matter what age the driver is. For a renewal 
process, the driver must prove that a visual acuity (eye) test 
has been passed within six months, or within one year as 
determined by a licensed health care professional.36,43
In Iowa, if visual acuity is less than 20/40 but at least 
20/50 (6/12–6/15 meters, 0.5–0.4), no driving is allowed 
when headlights are required. If visual acuity is less than 
20/50 but at least 20/70, driving at speeds over 35 mph is 
not allowed, in addition to no driving when headlights are Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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required. Driving is not permitted for visual acuity less than 
20/70. In respect of visual field requirements, left and right 
outside rearview mirrors are required if the field of vision 
is less than 140° but at least 115° for the single best eye 
(70° temporal and 45° nasal). For a field of vision less than 
115°, driving is not permitted.34 The normal renewal cycle 
in Iowa is five years, and for drivers who are 70 years of age 
or older it is two years.43
entitlement to disability pensions
The requirements for obtaining disability pensions due to low 
or no vision were found to be unique for each country. The 
most important aspects of disability pension qualifications 
have been summarized in Table 3 for the relevant European 
Union countries and US states. In the UK, people can claim a 
disability living allowance if they are certified blind (severely 
sight-impaired) or partially sighted (sight-impaired). Severely 
sight-impaired is defined as a visual acuity below 3/60 or 
1/18 (20/400 feet) tested with the Snellen test, or with visual 
acuity better than 3/60 but below 6/60 (20/200 feet) with a 
very restricted visual field. A person can be certified blind 
(or severely sight-impaired) if he or she is unable to perform 
work for which eyesight is essential. Partially sighted (sight-
impaired) corresponds to visual acuity from 3/60 to 6/60 
(20/400 to 20/200 feet) with a full field or visual acuity up 
to 6/24 (20/80 feet) with moderate contraction of the field, 
aphakia (lens removal), or opacities blocking vision in the 
eye itself, or with visual acuity of 6/18 (20/60 feet) or better 
if they have a gross visual field defect (of both eyes, such as 
hemianopia) or marked contraction of the visual field (eg, 
in retinitis pigmentosa or glaucoma). The visual acuity and 
visual field guidelines in the UK for partially sighted (sight-
impaired) designations suggest that a person can be certified 
as such if he or she is substantially and permanently disabled 
by defective vision caused by congenital defect, illness, or 
injury.44 Furthermore, a person is eligible to receive a dis-
ability living allowance only if he or she is below the age of 
65 years, has severe sight problems for at least three months, 
and is expected to have severe sight problems for another six 
months.45,46 Other European Union countries have different 
requirements for receiving disability allowances. Germany 
requires legal blindness for receiving a disability allowance. A 
blind person is someone whose central best-corrected visual 
acuity is 1/50 (20/1000 feet, 6/300 meters) in the better eye.47 
For France, 50% of disability corresponds to visual acuity 
below 3/10 (approximately 20/66 feet, 6/20 meters) in both 
eyes or 50% of visual field loss according to the Esterman 
score (binocular field). Eighty percent of disability corre-
sponds to visual acuity below 1/10 (20/200 feet, 6/60 meters) 
in both eyes, or 80% of visual field loss according to the 
Esterman score (binocular field). In France, complete blind-
ness is defined by visual acuity corresponding to no light 
perception. Legal blindness is visual acuity #1/20 (20/400 
feet, 6/120 meters, 0.05 decimal) of one eye and visual acu-
ity of the other eye below 1/20, with peripheral visual field 
deficiency when the visual field does not exceed 20° in the 
largest area.48,49
In Spain, compensation for the blind relies heavily on 
ONCE (Spanish National Organization for the Blind). Mem-
bership conditions are a best-corrected visual acuity of 0.1 
(1/10 on a Wecker scale) or lower, a visual field reduced to 10° 
or less, and Spanish citizenship.50,51 Between normal vision 
and blindness, there is a wide range of disabilities, eg, “visual 
disability”, “serious visual disability”, and “low vision”. In all 
three cases, visual acuity and visual field are used to obtain 
the degree of disability. Visual disability is defined as a per-
son who has reduced or very reduced visual capacity (even 
though the person is using glasses) and there is no possibility 
for improvement with surgical treatment.52 People with dis-
abilities can apply for the Pensión no Contributiva por Invali-
dez and Pensión por Incapacidad Permanente.53,54 In order 
to obtain any type of disability pension, it is necessary to 
pass an examination by specialized doctors. The application 
Table 3 Eligibility for disability pension benefits
Country Partially sighted Blind
UK VA of 3/60 to 6/60 with 
a full field, or 6/24 with 
field contraction, 
aphakia, or opacities 
blocking vision
VA of 3/60 or 1/18, or 6/30 
to 3/60 with a very restricted 
visual field, or 6/18 or better 
with marked contraction of 
visual field
germany Central BCVA of 1/50 in the 
better eye
France VA ,3/10 and .1/20 Central vision #1/20 of one 
eye, and VA of the fellow eye 
below 1/20, with peripheral 
visual field deficiency when 
the visual fields do not 
exceed 20° in the largest area
spain 1/10 on a Wecker scale, 
visual field reduced to 
10° or less
n/A
italy 1/20 or lower for both 
eyes
Absolute blindness
Us BCVA of 20/200 in the 
better eye, or limitations 
in the fields of vision no 
greater than 20°
n/A
Abbreviations: VA, visual acuity; BCVA, best-corrected visual acuity; n/A, not 
applicable.Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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procedure is relatively complicated and involves a panel of 
specialized doctors who decide whether the candidate is 
sufficiently disabled for eligibility.
Pensions for the blind (pensione ciechi civili) in Italy 
apply only to people with complete blindness. The require-
ments also include Italian citizenship and residency, and the 
citizen must be older than 18 years. Requirements for the 
partially blind pension (pensione per ciechi parziali) include 
a visual acuity of 1/20 (20/400 feet, 6/120 meters) or lower 
for both eyes. The candidate can be a European Union citizen 
with an Italian residence or a nonEuropean Union citizen 
with a work permit in Italy.55,56
In the US, people who are legally blind can obtain 
disability benefits. The requirements and definition for 
legal blindness are established in the Social Security Act, 
Section 216.57 A person is considered legally blind if central 
visual acuity is 20/200 (6/60 meters, 0.1 decimal) or less 
in the better eye with the use of a correcting lens. An eye 
with a field of vision limitation, such that the widest diam-
eter of the visual field subtends an angle of 20° or less, is 
considered to have a central visual acuity of 20/200 or less.57,58 
A person may also receive disability benefits even if he or 
she is not considered legally blind, if the vision problems 
alone or combined with other health problems prevent the 
person from working. For social security disability benefits, 
a person must have worked long enough to have paid social 
security taxes. For supplemental security income payments 
based on disability and blindness, it is not necessary to have 
been employed, but income and resources must be below 
state-imposed limits.
Discussion
Progressive eye diseases such as glaucoma can negatively 
impact vision and driving. Maintaining mobility outside the 
home is a main priority of glaucoma patients and a major 
contributor to quality of life.59–61 Evaluating driver’s license 
status and disability entitlements extends beyond typical 
quality of life assessments by highlighting the practical 
consequences of progressive eye disease.59 These outcomes 
may be useful in assessing disease progression and efficacy 
of treatments.
Licensing authorities hold the primary responsibility for 
establishing the fitness of license holders.62 The most common 
visual requirements for driver’s licensing are visual acuity and 
visual field. In most countries and jurisdictions, the visual 
acuity limit is 0.5 (20/40 feet, 6/12 meters). However, for 
monocular vision, the acuity limit is generally set higher. 
Monocular vision raises the visual acuity requirements in 
the better-seeing eye to 0.6 in European countries, whereas 
in the US, it is maintained at 0.5 in some states and is 
increased in others. Visual field limits are present in some 
of the driver’s license regulations and typically follow the 
European Union standard in European countries. The visual 
field limit is usually characterized by a radius or diameter, 
such as 60° or 120°. Variation in the US is somewhat greater. 
However, in states with visual field requirements, it is typi-
cally between 110° and 140°. Besides visual acuity and visual 
field, other characterizations of visual functions are some-
times present but are less well defined. Surprisingly, there 
is little focus on functional vision, such as actual driving 
performance. In some countries or jurisdictions, the field of 
vision has to be normal according to a competent medical 
authority. Measurement levels, defined by mean defect values, 
are not mentioned explicitly, despite the relevance to patients 
with eye disease. Most countries and states allow for exemp-
tions or restricted licenses.
Although we had originally intended to use both driver’s 
license forfeiture and entitlements to disability pension as 
milestones, our data show that disability pension require-
ments vary greatly from country to country, partly due to 
the multitude of rules and requirements that define legal 
blindness. For example, some countries distinguish between 
being partially sighted and blind, whereas in other countries, 
no such separation exists. As a result, disability pension 
entitlements cannot be standardized in a way that would be 
practical for use as a milestone or as a secondary endpoint 
in a clinical trial. In the absence of standardized national 
rules, one option would be to use the World Health Organi-
zation criteria for low vision and blindness to allow better 
comparability between countries in international trials. The 
World Health Organization defines low vision as “visual 
acuity of less than 6/18 but equal to or better than 3/60, or a 
corresponding visual field loss to less than 20°, in the better 
eye with the best possible correction”. Blindness is defined 
as “visual acuity of less than 3/60, or a corresponding visual 
field loss to less than 10°, in the better eye with the best pos-
sible correction”.63
Milestone approach
Reductions in intraocular pressure and the rate of visual 
field progression are commonly used to assess the value 
of glaucoma treatments,64 but these are not as complete in 
evaluating the impact of glaucoma on a patient’s quality of 
life. Maintaining a driver’s license is a performance-based 
measure and is not subject to the bias of self-reported 
questionnaires.61,65 Using health outcome measures Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
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complements clinical measures and may help establish the 
effectiveness of competing treatments (Figures 1 and 2). For 
example, if a superior treatment can stop or delay the pro-
gression of an eye disease, the milestones can be postponed. 
This outcome can be reported as gained time with ability 
to drive. Treatment goals would include maintaining visual 
function above the legal driving standard so that glaucoma 
patients continue to drive for as long as it is safe to do so. 
Visual standards should be set to a binocular visual acuity 
of 0.5 or better and a visual field of 120° or better in the 
horizontal meridian.
There are a few limitations to the milestone approach. 
For clinical studies using driver’s licensing as a secondary 
endpoint, it would be important to adjust for education, race, 
cognitive ability, and disease comorbidities,66,67 which influ-
ence driving ability independent of glaucoma status. Also, 
there is considerable heterogeneity for age-related driver’s 
license renewal between countries, and older drivers often 
voluntarily reduce their driving frequency.68,69 Therefore, it 
may be more accurate to inquire about driving status, not 
just licensing. It is worth considering whether “driving a car” 
would be a better milestone rather than the administrative 
rules for maintaining a driver’s license. Hence, the question 
would become “At what stage of the disease do patients stop 
driving cars, and for what reason?”. A cross-sectional or a lon-
gitudinal study approach could be used. With cross-sectional 
data, the tendency to drive could be estimated as a function of 
relevant variables, such as disease progression, visual acuity, 
visual field, and other visual function parameters, sociode-
mographic and socioeconomic variables, and urbanization. 
The function could be estimated as a probability regression 
model, such as a logistic regression. If a longitudinal data set 
is available, either collected prospectively or retrospectively, 
Normal
vision
Low
vision
No driving Pension Time
Figure 1 example of how revocation of the driver’s license and entitlement to 
disability  pensions  could  be  considered  milestones.  The  downward-sloping  line 
represents progression of visual impairment over time.
Normal
vision
Driving
limit
Pension
limit
Low
vision
Saved
driving
time
Saved
pension
time
Time
Product A
Product B
Figure 2 Driver’s license forfeiture and entitlement to disability pensions can be 
used as endpoints in clinical trials. The results may be reported as time saved due 
to delaying milestones.
the statistical method of survival analysis can be carried out, 
whereby “survival” is defined as maintained ability to drive, 
and the “fatal” event is defined as giving up driving a car. 
Proportional hazard modeling could be used to estimate the 
effect of disease progression, visual acuity, visual field, other 
visual function parameters, sociodemographic and socio-
economic variables, and urbanization. Such a study would 
provide crucial data that would associate the endpoints used 
in clinical trials with the ability to drive a car. Information 
about driving behavior for eye patients can often be obtained 
from visual functioning questionnaires such as the National 
Eye Institute Visual Function Questionnaire. To study driving 
behavior in glaucoma patients, it might not be necessary to 
conduct new studies.
We acknowledge several limitations to our study. We 
focused on the comparison of driver’s license regulations 
between only two states within the US and only five countries 
(those that account for more than half the population of 
Europe) out of 27 countries in the European Union. Moreover, 
we did not consider countries with more populations, such 
as India or China, where the relevant information is more 
difficult to gather.
Conclusion
The driver’s license endpoint can be standardized as a best-
corrected visual acuity of at least 0.5 and a visual field of at 
least 120°. This is consistent with the driver’s license require-
ments in most countries and jurisdictions. Driver’s license 
forfeiture, rather than entitlement to disability pensions, 
could be considered a milestone or secondary endpoint in 
the characterization of a progressive eye disease, such as 
open-angle glaucoma. Delaying these milestones is a useful Clinical Ophthalmology 2010:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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goal of therapeutic interventions, because it may decrease 
personal and societal burden and cost.
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